Phase 1/2 Trial to Assess the Activity of Entrectinib in Children and Adolescents with Recurrent or Refractory Solid Tumors Including Central Nervous System (CNS) Tumors

被引：0

作者：

Desai, A. V. ^{[1
]}

Gajjar, A. ^{[2
]}

Gauvain, K. ^{[3
]}

Basu, E. M. ^{[4
]}

Macy, M. E. ^{[5
]}

Maese, L. ^{[6
]}

Sabnis, A. J. ^{[7
]}

Foster, J. ^{[8
]}

Shusterman, S. ^{[9
]}

Yoon, J. ^{[10
]}

Weiss, B. ^{[11
]}

Abdelbaki, M. S. ^{[12
]}

Farid-Kapadia, M. ^{[13
]}

Meneses-Lorente, G. ^{[14
]}

Cardenas, A. ^{[15
]}

Hutchinson, K. E. ^{[15
]}

Bergthold, G. ^{[16
]}

Maneval, E. Chow ^{[17
]}

Fox, E. ^{[18
]}

Robinson, G. W. ^{[2
]}

机构：

[1] Univ Chicago, Med Ctr, Sect Hematol Oncol Stem Cell Transplantat, Chicago, IL 60637 USA

[2] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

[3] Washington Univ, Sch Med, Div Hematol & Oncol, St Louis, MO USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA

[5] Childrens Hosp Colorado, Dept Hematol Oncol & Bone Marrow Transplantat, Aurora, CO USA

[6] Univ Utah, Huntsman Canc Inst, Primary Childrens Hosp, Salt Lake City, UT USA

[7] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA

[8] Texas Childrens Canc Ctr, Dept Pediat, Houston, TX USA

[9] Dana Farber Canc Inst, Boston Childrens Canc & Blood Disorders Ctr, Boston, MA 02115 USA

[10] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, San Diego, CA 92103 USA

[11] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA

[12] Ohio State Univ, Nationwide Childrens Hosp, Div Hematol Oncol & BMT, Columbus, OH 43210 USA

[13] F Hoffmann La Roche Ltd, Biometr Dept, Mississauga, ON, Canada

[14] Roche Prod Ltd, Clin Pharmacol, Welwyn Garden City, Herts, England

[15] Genentech Inc, Pediat Oncol, San Francisco, CA USA

[16] F Hoffmann La Roche, Prod Dev Oncol, Basel, Switzerland

[17] Ignyta Inc, Dept Oncol, San Diego, CA USA

[18] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

来源：

PEDIATRIC BLOOD & CANCER | 2019年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FP122 SIOP

引用

页码：S69 / S70

页数：2

共 50 条

[1] Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.
Robinson, Giles W.
Gajjar, Amar J.
Gauvain, Karen Marie
Basu, Ellen M.
Macy, Margaret E.
Maese, Luke Devon
Sabnis, Amit J.
Foster, Jennifer Haunani
Shusterman, Suzanne
Yoon, Janet
Weiss, Brian D.
Abdelbaki, Mohamed
Farid-Kapadia, Mufiza
Meneses-Lorente, Georgina
Cardenas, Alison
Hutchinson, Katherine
Bergthold, Guillaume
Maneval, Edna Chow
Fox, Elizabeth
Desai, Ami Vijay
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] Updated Entrectinib Data From a Phase 1/2 Trial in Children and Adolescents With Recurrent or Refractory Solid Tumors, Including Primary Central Nervous System (CNS) Tumors
Desai, A. V.
Robinson, G. W.
Basu, E. M.
Foster, J.
Gauvain, K.
Sabnis, A. J.
Macy, M. E.
Maese, L.
Yoon, J.
Cash, T.
Abdelbaki, M. S.
Nazemi, K. J.
Weiss, B.
Chohan, S.
Cardenas, A.
Hutchinson, K. E.
Bergthold, G.
Gajjar, A.
Fox, E.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S122 - S122
[3] ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS
Robinson, Giles
Desai, Ami
Gauvain, Karen
Basu, Ellen
Dorris, Kathleen
Maese, Luke
Sabnis, Amit
Foster, Jennifer
Shusterman, Suzanne
Yoon, Janet
Weiss, Brian
Abdelbaki, Mohamed
Farid-Kapadia, Mufiza
Meneses-Lorente, Georgina
Cardenas, Alison
Hutchinson, Katherine
Bergthold, Guillaume
Maneval, Edna Chow
Fox, Elizabeth
Gajjar, Amar
NEURO-ONCOLOGY, 2019, 21 : 186 - 186
[4] Updated Entrectinib Data in Children and Adolescents with Recurrent or Refractory Solid Tumors, Including Primary CNS Tumors
Miyachi, Mitsuru
Desai, Ami
Robinson, Giles
Basu, Ellen
Foster, Jennifer
Gauvain, Karen
Sabnis, Amit
Gajjar, Amar
PEDIATRIC BLOOD & CANCER, 2020, 67
[5] ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS
Robinson, Giles
Desai, Ami
Basu, Ellen
Foster, Jennifer
Gauvain, Karen
Sabnis, Amit
Shusterman, Suzanne
Macy, Margaret
Mease, Luke
Yoon, Janet
Cash, Thomas
Abdelbaki, Mohamed
Nazemi, Kellie
Pratilas, Christine
Weiss, Brian
Chohan, Saibah
Cardenas, Alison
Hutchinson, Katherine
Bergthold, Guillaume
Gajjar, Amar
NEURO-ONCOLOGY, 2020, 22 : 344 - 344
[6] Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors.
Desai, Ami Vijay
Robinson, Giles W.
Basu, Ellen M.
Foster, Jennifer
Gauvain, Karen
Sabnis, Amit
Shusterman, Suzanne
Macy, Margaret E.
Maese, Luke
Yoon, Janet
Cash, Thomas
Abdelbaki, Mohamed
Nazemi, Kellie
Weiss, Brian D.
Chohan, Saibah
Cardenas, Alison
Hutchinson, Katherine
Bergthold, Guillaume
Gajjar, Amar J.
Fox, Elizabeth
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[7] A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors
Pilbeam, Kristy L.
Pradhan, Kamnesh
Croop, James
Minard, Charles G.
Liu, Xiaowei
Voss, Stephan D.
Isikwei, Emasenyie
Berg, Stacey L.
Reid, Joel M.
Fox, Elizabeth
Weigel, Brenda J.
PEDIATRIC BLOOD & CANCER, 2024, 71 (03)
[8] A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Chuk, Meredith K.
Widemann, Brigitte C.
Minard, Charles G.
Liu, Xiaowei
Kim, AeRang
Bernhardt, Melanie Brooke
Kudgus, Rachel A.
Reid, Joel M.
Voss, Stephan D.
Blaney, Susan
Fox, Elizabeth
Weigel, Brenda J.
PEDIATRIC BLOOD & CANCER, 2018, 65 (08)
[9] PHASE I TRIAL OF DASATINIB, LENALIDOMIDE, AND TEMOZOLOMIDE IN CHILDREN WITH RELAPSED OR REFRACTORY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Dhall, Girish
Haley, Kelley
Finlay, Jonathan
Rushing, Teresa
Sposto, Richard
Seeger, Robert
NEURO-ONCOLOGY, 2013, 15 : 166 - 166
[10] A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system
Manley, Peter E.
Trippett, Tanya
Smith, Amy A.
Macy, Margaret E.
Leary, Sarah E. S.
Boklan, Jessica
Cohen, Kenneth J.
Goldman, Stewart
Kilburn, Lindsay B.
Dhall, Girish
Devin, Jeanne
Herzog, Cynthia E.
Partap, Sonia
Fauchet, Floris
Badreddine, Emmy
Bernard, John P.
Chi, Susan N.
PEDIATRIC BLOOD & CANCER, 2018, 65 (09)

← 1 2 3 4 5 →